Eli Lilly & Co $65.95

down -0.13


23/9/2014 04:00 PM  |  NYSE : LLY  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get LLY Trend Analysis - it has outperformed the S&P 500 by 8%

Partner Headlines

  1. Meet 5 Top International Stocks Not Based In China

    IBD
  2. Dyax Offers Highlights of Recent Progress in Licensing, Funded-Research ...

    Benzinga
  3. Lipocine Inc Halted: Feds Eye Safety, Efficacy Of Testosterone

    Benzinga
  4. Drug giants target Alzheimer's

    IBD
  5. What Is A High Risk Market?

    Benzinga
  6. Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures

    GuruFocus
  7. Markets Little Changed In Low Volume And Slow News Ahead Of Long Weekend

    Benzinga
  8. Deutsche Bank: Eli Lilly At 'Critical Stage' In Its Journey

    Benzinga
  9. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold

    Benzinga
  10. New Type 2 Diabetes Treatment Jardiance Tablets For Adults Now Available ...

    Benzinga
  11. UPDATE: Tigress Initiates Coverage On Eli Lilly

    Benzinga
  12. Dow Suffers 300 Point Drop; S&P 500 And Nasdaq Also Tumble

    Benzinga
  13. Stocks Lower As Earnings Season Takes Back Seat To Geopolitical Uncertainties

    Benzinga
  14. Thursday Morning Earnings Reports

    Benzinga
  15. Earnings Scheduled For July 24, 2014

    Benzinga
  16. New Study Shows Beta-Amyloid Imaging Is Associated With Altered Diagnosis ...

    Benzinga
  17. Lilly And Immunocore Enter Immunotherapy Agreement To Co-Discover And Co-Develop ...

    Benzinga
  18. Benzinga's Top #PreMarket Gainers

    Benzinga
  19. US Stock Futures Mostly Higher Ahead Of Goldman Sachs Earnings

    Benzinga
  20. Barclays Downgrades Pharmaceutical Sector

    Benzinga
  21. UPDATE: Barclays Upgrades Eli Lilly Despite Sector Downgrade

    Benzinga
  22. Benzinga's Top Upgrades

    Benzinga
  23. Eli Lilly is on the Right Track

    GuruFocus
  24. Celgene Sees Better Results For Psoriatic Arthritis

    IBD
  25. Eli Lilly Bets Big on Diabetes, Cancer Drugs

    FoxBusiness
  26. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD
  27. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  28. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted ...

    Benzinga
  29. John Paulson's 4 Stocks Trading for Less Than He Paid for Them

    GuruFocus
  30. Lilly Says Abemaciclib in Phase 1 Study Demonstrated Single-Agent Activity

    Benzinga
  31. Eli Lilly insulin trial succeeds

    IBD
  32. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  33. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  34. Eli Lilly's Basal Insulin Outperforms Lantus In Trial

    IBD
  35. UPDATE: Eli Lilly Announces Peglispro Shows Superiority Compared to Insulin ...

    Benzinga
  36. Can Pfizer Make Up Its Loss?

    GuruFocus
  37. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  38. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  39. Will Pfizer's Q1 2014 Earnings Beat the Street on May 5, 2014?

    GuruFocus
  40. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  41. Novo Nordisk Struggles In U.S. Market; Q1 Sales Miss

    IBD
  42. Novo Nordisk Q1 Revenue Misses; Guidance Lowered

    IBD
  43. Vanguard Health Care Fund's Top Quarterly Holdings

    GuruFocus
  44. Actavis Earns Over-The-Top Q1

    IBD
  45. Actavis Beats Q1 Views, Looks To Supersized Future

    IBD
  46. Actavis Q1 Earnings Beat On Generic Cymbalta Surprise

    IBD
  47. China Rule Change Further Opens Yuan To World Markets

    IBD
  48. These Three Pharmaceutical Companies Shake The Market With Their Deal

    GuruFocus
  49. Drugmakers' Q1 was anemic

    IBD
  50. Eli Lilly Jr. Made His Firm A Pharmaceutical Power

    IBD
Trading Center